S teven G. Segal, is an Executive-in-Residence/Lecturer at Boston University’s Questrom School of Business where he developed and teaches a graduate level course in private equity and leverage buyouts. He is also a Special Limited Partner of J.W. Childs Associates, where he helps guide the strategic direction of several of the firm’s portfolio companies through his role as a director and is a co-investor with the firm. He has provided expert court-room testimony in multi-million dollar litigation for third parties.
In 1995, Mr. Segal was a co-founding partner of J.W. Childs Associates, a Boston-based private equity investment firm that raised $3.5 billion of equity capital from 1996-2006. The firm focuses on investing in middle-market growth companies, primarily in the consumer products, health care services and specialty retail sectors. During this period, the firm completed more than 40 transactions with a total transaction value in excess of $11 billion.
In his capacities at the firm, Mr. Segal had broad responsibilities for raising capital from leading institutional investors, and for originating, analyzing, negotiating, financing and managing leveraged buyout transactions. Mr. Segal was actively involved in the strategic and financial policy of several of the firm’s portfolio companies and in the investment decision process for all of the firm’s investments.
Mr. Segal was previously a Managing Director at Thomas H. Lee Company, a Boston-based private equity investment firm, from 1987 to 1995 where he had similar responsibilities.
- Serves or has served on the Board of Directors of The NutraSweet Company; W/S Packaging Corp.; InSight Health Services, Inc.; Universal Hospital Services, Inc; Quality Farm & Country, Inc.; Jillian’s Entertainment Corp.; International DiverseFoods, Inc.; National Nephrology Associates, Inc.; Big V Supermarkets, Inc.; Maax, Inc.; General Nutrition Centers (GNC), Inc.; Ghirardelli Chocolate Company; Fitness Quest, Inc.; Round Grille, Inc. (d/b/a FiRE + iCE);
- Advisory Board of NextView Ventures, a seed stage venture capital firm in Boston.